• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX AFX2; BIFURCATED STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX AFX2; BIFURCATED STENT GRAFT Back to Search Results
Model Number BEA22-90/I16-30
Device Problem Unintended Movement (3026)
Patient Problem Failure of Implant (1924)
Event Date 01/24/2023
Event Type  Injury  
Manufacturer Narrative
The device involved in this event will not be returned for evaluation as it remains implanted in the patient.Patient medical records and imaging studies will be requested for further evaluation by the clinical specialist.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.Device iteration is afx2.
 
Event Description
The patient was initially implanted with an afx2 bifurcated stent graft and an afx vela infrarenal to treat an abdominal aortic aneurysm (aaa).Approximately four (4) years subsequent to the initial procedure, the patient underwent a re-intervention due to implant movement, characterized by a decrease in overlap length.The attending physician opted to proceed with an afx vela infrarenal implantation.The final patient status was reported as being in stable condition.
 
Manufacturer Narrative
The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, it is endologix practice to make at least three good-faith efforts to retrieve a reported adverse event/incident-related device as well as medical records and medical imaging.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.The review confirms there were no manufacturing or processing non-conformities identified that would contribute to the reported adverse event/incident.The device was not returned to endologix for evaluation.A clinical evaluation of the event/incident was completed.An examination of medical records and/or medical imaging received by endologix shows the overlap length became shorter and the additional endovascular procedure are confirmed.This is consistent with the reported event/incident.The most likely causation for the reported event is user related.It was noted that the insertion technique/process was off-label as the device ifu indicates the overlap between afx2 main body and extension should be 30-40mm; however, an overlap of only 20mm was reported as achieved.In addition, there was off-label concomitant use with non-endologix products outside the ifu.Procedure-related harms of this complaint could not be determined with the medical records available for review.The final patient status was reported to be stable.No additional investigation of this reported event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar events/incidents.Device iteration is afx2.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX2
Type of Device
BIFURCATED STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX
2 musick
irvine CA 92618
Manufacturer (Section G)
ENDOLOGIX
2 musick
,
irvine CA 92618
Manufacturer Contact
gary kirchgater
2 musick
,
irvine, CA 92618
8009832284
MDR Report Key16414617
MDR Text Key309954124
Report Number2031527-2023-00031
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00818009015136
UDI-Public(01)00818009015136(17)190626
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional,Company Representative
Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup
Report Date 02/02/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/21/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/26/2019
Device Model NumberBEA22-90/I16-30
Device Lot Number1952240-004
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/15/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/18/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
AFX VELA INFRARENAL 1768216009
Patient Outcome(s) Required Intervention;
Patient SexMale
-
-